Status:
NOT_YET_RECRUITING
Increasing Access to Definitive Treatment for Prostate Cancer
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
United States Department of Defense
Dana-Farber Cancer Institute
Conditions:
Prostate Cancer
Eligibility:
MALE
22+ years
Phase:
NA
Brief Summary
Investigators will address the overarching challenge of advancing health equity and reducing disparities in prostate cancer by informing efforts to reduce travel burden in prostate cancer (PCa) treatm...
Detailed Description
The following are the three aims of the proposal: Aim 1: Determine how travel distance for PCa treatment impacts the outcome Aim 2: Pilot a trial by offering ridesharing services for Black men seeki...
Eligibility Criteria
Inclusion
- Black man
- Intermediate-or high-risk prostate cancer
- Seeking prostate cancer definitive treatment (surgery or radiation) at the Mass General Brigham Prostate Cancer Outreach Clinic
- Reside in a census tract in Massachusetts recognized as having a high travel burden based on results of Aim1 of the Project OR identifies as having difficulties or challenges when it comes to transportation, particularly in relation to getting to and from medical appointments
Exclusion
- None
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06034431
Start Date
September 1 2023
End Date
June 1 2026
Last Update
September 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115